Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropanamine-dihydrochloride

EU orphan designation number: EU/3/18/1972   
Active ingredient: 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropanamine-dihydrochloride
Indication: Treatment of soft tissue sarcoma
Sponsor: CATS Consultants GmbH
Ussenried 7, 87463 Dietmannsried, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/02/2018 Orphan designation EMA/OD/202/17 (2018)1256 of 22/02/2018